CAS Clinical Trial
Official title:
Cumulated Ambulation Score and Length of Hospital Stay After TKA
| Verified date | June 2015 |
| Source | University of Lausanne Hospitals |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Switzerland: Swissmedic |
| Study type | Observational [Patient Registry] |
The purpose of the study is to prospectively evaluate patients who underwent total knee arthroplasty (TKA) using the Cumulated Ambulation Score (CAS)
| Status | Completed |
| Enrollment | 73 |
| Est. completion date | June 2015 |
| Est. primary completion date | September 2014 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: Adults after elective TKA - Exclusion Criteria: No consent form signed, neurological impairment |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | CHUV - Hopital Orthopedique | Lausanne | Vaud |
| Lead Sponsor | Collaborator |
|---|---|
| University of Lausanne Hospitals |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Destination at the end of the hospitalisation | Record the patients' destination at the end of the in-hospital stay: home, rehabilitation centre, residential home or other. | at the moment of departure from in-hospital care | No |
| Primary | CAS value | Record the CAS values for the first three operative days as mentioned in the protocol | The 3rd day after TKA | No |
| Secondary | Length of stay | Record number of in-hospital days | between 4 days and 2 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04825145 -
Preeclampsia and Contact Activation
|